Baker McKenzie Switzerland and Baker McKenzie Wong & Leow, have advised Bio-Rad Laboratories as borrowers and guarantors in connection with a USD 200 million credit agreement arranged by Wells Fargo Securities LLC, JPMorgan Chase Bank N.
Tags :Slider
Norton Rose Fulbright has strengthened its German antitrust and competition law practice with the appointment of Dr Jens Steger (pictured). Steger joins as a partner in the firm’s Frankfurt office from K&L
Niederer Kraft Frey has advised Calibre Scientific Inc. on the acquisition of Ruwag Handels AG. Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research,
VR Group, a passenger, logistics and maintenance service company owned by the Finnish state, has acquired the Swedish MTR Express AB from MTR Nordic AB. MTR Express operates a train connection between Stockholm and Gothenburg.
UBS Group AG has successfully completed its offering of USD 1bn AT1 Notes, which are redeemable at the option of UBS after seven years and two months. The Notes are “high trigger” regulatory capital instruments
Deutsche Invest acquired the majority of Iconia Group, a Swiss-based company that provides B2B customer engagement services for the global luxury industry. Deutsche Invest acted as lead investor on this investment, joined by funds
Bobst Group has successfully completed its issuance of CHF 200,000,000 senior unsecured bonds with a maturity date in 2029 and a coupon of 2.545%. The bonds will be listed on the SIX Swiss Exchange. UBS Investment Bank, BNP
Baker McKenzie has advised Sumitomo Rubber Industries, on the share transfer of Lonstroff. The company is a subsidiary for the manufacture and sale of rubber parts for medical applications. Sumitomo Rubber Industries concluded an agreement
Krones AG agreed to acquire all shares in Netstal Maschinen AG from KraussMaffei. Netstal is a leading supplier of injection molding machines to the beverage market (PET preforms and caps) as well as to the
Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20m in the extension of its Series A funding to further develop its pivotal solution to a safer, lower-cost, proliferation-resistant nuclear energy
